---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-099018"
form_type: "8-K"
ticker: "BRTX"
cik: "0001505497"
company_name: "BioRestorative Therapies, Inc."
filed_at: "2026-09-11T13:29:03+00:00"
generated_at: "2026-09-11T13:30:06.016104+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# BioRestorative VP of R&D resigns claiming Good Reason; company disputes severance demand

## Summary
- Mr. Silva resigned as VP of R&D effective Sept 4, 2026, asserting 'Good Reason' under employment agreement due to alleged Change in Control from June 2026 board changes.
- Silva demands ~$1.29M cash severance, equity award acceleration, and benefit continuation; company does not accept validity of agreement or his characterizations.
- Board acknowledges resignation for records but reserves all rights; only accrued unpaid salary to be paid pending investigation.
- Board investigating circumstances around Employment Agreement and agreements with former CEO and former CFO before any payments.

## SEC filing metadata
- accession: 0001213900-26-099018
- form_type: 8-K
- ticker: BRTX
- cik: 0001505497
- company_name: BioRestorative Therapies, Inc.
- filed_at: 2026-09-11T13:29:03+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1505497/000121390026099018/0001213900-26-099018-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1505497/000121390026099018/ea0305246-8k_biore.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-099018
- JSON: https://secwatch.observer/filing/0001213900-26-099018.json
- Plain text: https://secwatch.observer/filing/0001213900-26-099018.txt

## Key facts
- Executive change
  Mr. Silva resigned as Vice President of Research and Development at BioRestorative Therapies, Inc..
  - Action: resigned
  - Role: Vice President of Research and Development
  source text: On September 4, 2026, BioRestorative Therapies, Inc. (the “ Company ”) received a notice of resignation from Mr. Silva from his employment with the Company, including as the Company’s Vice President of Research and Development, and from each other position (if any) he held as an officer of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1505497/000121390026099018/0001213900-26-099018-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.